Skip to main content
. 2021 May 27;12(15):4497–4504. doi: 10.7150/jca.58094

Figure 1.

Figure 1

Decision curve analysis to calculate the clinical net benefit of each model for overall survival (A) and cancer-specific survival (B). The baseline model includes three covariates (i.e., age, lymphatic invasion, and stage), and the full model includes four covariates (i.e., age, lymphatic invasion, stage, and CLR). All, a line that all patients are surviving; None, a line that no patient is surviving.